Loading...
Market
Will Dexcom Stelo achieve 100,000 units sold by the end of 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official sales reports from Dexcom or financial disclosures
Story
Dexcom Launches First OTC Glucose Monitor in U.S.
Aug 26, 2024, 10:06 AM
Dexcom has launched Stelo, the first over-the-counter continuous glucose monitor (CGM) in the United States. The device, announced earlier this year at CES 2024, aims to provide a more affordable option for people with Type 2 diabetes to access CGMs. The availability of Stelo marks a significant step in the fight against diabetes by improving accessibility to essential monitoring technology.
View original story
Similar markets
Less than 10,000 units • 25%
10,000 to 50,000 units • 25%
50,000 to 100,000 units • 25%
More than 100,000 units • 25%
Less than 50,000 • 25%
50,000 to 100,000 • 25%
100,000 to 150,000 • 25%
More than 150,000 • 25%
